Global Perspective of Cpap Adherence Publisher



Rosen J¹ ; Najafi A² ; Sadeghniiathaghighi K² ; Gupta R³ ; Jankovic SM⁴ ; Shen J⁵ ; Lee YJ⁶ Show Affiliations
Source: CPAP Adherence: Factors and Perspectives Published:2022

Abstract

Approximately one billion adults worldwide ages 30–69 years have obstructive sleep apnea (OSA), while the number of individuals with moderate-to-severe OSA is estimated to be nearly 425 million (Benjafield et al., Lancet Respir Med. 7(8):687–698, 2019). These numbers continue to increase in parallel with global estimates of chronic disease, perpetuating a vicious cycle: chronic disease is often brought upon by poor health, and OSA is a known contributor to poor health outcomes in the absence of proper and timely treatment (Benjafield et al., Lancet Respir Med. 7(8):687–698, 2019). Given its multifactorial socioeconomic and health consequences, OSA poses a high societal burden. At present, the care and treatment of patients with OSA varies greatly by country and even provinces or states. Nasal continuous positive airway pressure (CPAP) is internationally recognized as the “gold” standard for OSA treatment (Rotenberg et al., J Otolaryngol Head Neck Surg. 45:23, 2016). Despite its usage, worldwide estimates of CPAP efficacy are low due to problematic patient adherence and absent government-funded benefits. This chapter aims to explore CPAP adherence rates from an international perspective. Included in this chapter is a list of excerpts from professionals around the world in the field of sleep medicine sharing their perspective and their country’s statistics regarding CPAP adherence. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.